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Background: Some women continue smoking during pregnancy despite the extensive information available on
the dangers smoking poses to their fetus. This study aimed to examine the prevalence and determinants of
smoking before and during pregnancy and the extent of smoking during pregnancy from a European perspective
in relation to maternal sociodemographic characteristics, health literacy, morbidity, and pregnancy-related factors.
Methods: This multinational, web-based study evaluated pregnant women and new mothers in 15 European countries
recruited from October 2011 to February 2012. Data were collected via an anonymous online questionnaire.
Results: Of 8344 women included, 2944 (35.3%) reported smoking before pregnancy, and 771 (26.2%) continued
smoking during pregnancy, 88 (11.4%) of whom smoked more than 10 cigarettes per day. There was a wide variation
among the 15 European countries in smoking rates before and during pregnancy, ranging from 25.0% (Sweden) to
50.0% (Croatia) before and 4.2% (Iceland) to 18.9% (Croatia) during pregnancy. Women who lived in Eastern Europe,
without a spouse/partner, with a low education level and unplanned pregnancy, who did not take folic acid, and
consumed alcohol during pregnancy were the most likely to smoke before pregnancy. Women who lived in Eastern or
Western Europe, without a spouse/partner, with a low education level and health literacy, being a housewife, having
previous children and unplanned pregnancy, and who did not take folic acid were the most likely to continue smoking
during pregnancy. Women who smoked more than 10 cigarettes per day during pregnancy were the most likely to be
living in Eastern Europe and to have a low education level.
Conclusion: Women with fewer resources living in Western or Eastern Europe are more likely not only to smoke
before pregnancy but also to continue smoking during pregnancy. These high-risk women are characterized as living
alone, having high school or less as highest education level, having low health literacy, being a housewife, having
previous children, having unplanned pregnancy, and no use of folic acid. Our findings indicated that focus on smoking
cessation is important in antenatal care in Europe as many women smoke before pregnancy, and still continue to do
so in pregnancy.
Keywords: Pregnancy, Smoking, Prevalence, Determinants, Europe* Correspondence: janne.smedberg@farmasi.uio.no
1Department of Pharmacy, School of Pharmacy, University of Oslo, PO Box
1068, Blindern, 0316 Oslo, Norway
Full list of author information is available at the end of the article
© 2014 Smedberg et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public
Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this
article, unless otherwise stated.
Smedberg et al. BMC Pregnancy and Childbirth 2014, 14:213 Page 2 of 16
http://www.biomedcentral.com/1471-2393/14/213Background
Maternal smoking during pregnancy poses a significant
threat to the unborn child. As there is no safe lower limit
of cigarette use during pregnancy, the World Health
Organization advises pregnant women to abstain from all
cigarette use [1]. Women are more likely to stop smoking
during pregnancy than at other times [2], yet some con-
tinue smoking despite the extensive information available
on the dangers that smoking poses to their fetus. Smoking
during pregnancy increases the risk of spontaneous preg-
nancy loss, preterm delivery, low birth weight (LBW) in-
fant, small for gestational age infant, preterm premature
rupture of membranes, placental abruption, placenta pre-
via, and stillbirth [3-9]. A dose-related relationship be-
tween increased risk and heaviness of smoking has been
shown for spontaneous pregnancy loss, LBW, placental
abruption, and stillbirth.
It has been estimated that 10%-27% of the pregnant
women in the European Union continue smoking during
pregnancy [10]. Here it should be noted that the true
prevalence of smoking during pregnancy may be difficult
to discern, not only because some countries lack national
statistics but also because of possible underreporting in
studies relying on self-report [11]. Social norms discour-
aging smoking during pregnancy today may lead women to
fail to disclose their true smoking status. Prevalence rates
appear to have peaked and have begun to decline in most
industrialized countries [12], whereas in other countries,
such as in Eastern Europe and the Mediterranean area,
smoking is becoming increasingly common among young
women in general [13], and hence also possibly among
pregnant women. Together with growing concern over
smoking as an epidemic in the Third World in the future
[14], smoking will continue to be one of the most import-
ant preventable risk factors for poor pregnancy outcomes.
The lack of sustained benefit from interventions dur-
ing pregnancy [15-18] suggests that our understanding
of the determinants of smoking during pregnancy re-
mains inadequate. A large number of studies on possible
sociodemographic predictors for smoking in pregnancy
have been published internationally [19-24]. However, the
lack of uniform study design, data collection, and study
population make it difficult to assess whether these risk
factors for smoking in pregnancy are similar in frequency
and effects across countries. Furthermore, little is known
about the impact of maternal morbidity and poor health
literacy on smoking cessation when women who smoke
become pregnant. In particular, there is a scarcity of
comparable national data on smoking during pregnancy
in Europe.
Hence, there is need for a study that simultaneously
and uniformly collects data on smoking during preg-
nancy across nations. This can provide more insights
into the burden of smoking during pregnancy in Europeand, not least, give clinicians and public health re-
searchers useful information. Understanding what charac-
terizes women who continue smoking during pregnancy
would clearly lead to great potential health gains for both
mother and child, and for society as a whole. The know-
ledge could be used to tailor preconception prevention
strategies as well as interventions during pregnancy. Specif-
ically, this knowledge is relevant for healthcare personnel
(midwifes, doctors, and pharmacists) who offer smoking
cessation support and sell nicotine replacement therapy to
pregnant women who want to quit smoking.
The purpose of this study is to describe the prevalence
and extent of smoking during pregnancy in 15 European
countries in relation to maternal sociodemographic char-
acteristics, health literacy, morbidity, and pregnancy-
related factors. We used data from a multinational,
cross-sectional, web-based study on pregnant women
and new mothers.
Methods
Study design, population, and data collection
This is a sub-study of a multinational, cross-sectional, web-
based study conducted in countries in Western, Northern,
and Eastern Europe, South America, North America, and
Australia, investigating medication use in pregnancy with
focus on attitudes, perception of risk, and mental well-
being [25]. For this study, we included only European
countries (Austria, Croatia, Finland, France, Iceland, Italy,
the Netherlands, Norway, Poland, Russia, Serbia, Slovenia,
Sweden, Switzerland, and the United Kingdom). Both
pregnant women at any gestational week and new mothers
with a child younger than one year old were eligible to
participate. Data were collected using an anonymous, self-
completed, online questionnaire (http://www.questback.com)
that was accessible for a period of 2 months in each partici-
pating country between October 2011 and February 2012.
The questionnaire was open to the public via utilization
of banners (study invitation) on national websites and/or
social networks commonly visited and consulted by preg-
nant women and/or new mothers. Information about re-
cruitment tools utilized and Internet penetration rates in
each participating country are described in detail elsewhere
[25]. Here, the study’s external validity was assessed by
comparing sociodemographic and lifestyle characteristics
of the sample on an individual country level with those of
the general birthing population in the country [25]. Over-
all, the birthing population in each participating country
was reflected adequately by the sample with respect to age
and smoking habits.
The questionnaire was first developed in Norwegian
and English and then translated into the other relevant
languages. A pilot study in four countries (n = 47) elic-
ited no major changes. Collected data were searched for
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country of residency, sociodemographics, date and time
of questionnaire completion) but none were identified.
Dependent variables
Smoking was the outcome variable, measured by the ques-
tions: ‘Did you smoke cigarettes before becoming preg-
nant?’ and ‘Do you/did you smoke during pregnancy?’
Women, who smoked before but not during pregnancy
were classified as having quit smoking in pregnancy.
Women who smoked before and during pregnancy were
classified as continuing smoking in pregnancy.
Extent of smoking was measured by the question ‘How
many cigarettes (on average) do you/did you smoke per day
during pregnancy?’ The response alternatives were: ‘< 1,’
‘1-5,’ ‘6-10,’ or ‘≥ 11’.
Independent variables
Maternal sociodemographic characteristics included coun-
try of residency categorized according to the three regions
Western Europe (Austria, France, Italy, Switzerland, the
Netherlands, the United Kingdom), Northern Europe
(Finland, Iceland, Norway, Sweden), and Eastern Europe
(Croatia, Poland, Russia, Serbia, Slovenia), age, marital
status, education level, working status, first language,
and previous children. Pregnancy-related factors included
planned pregnancy, folic acid use before and/or during
pregnancy, and alcohol use during pregnancy. The vari-
ables were categorized as in Table 1.
Health literacy was measured by a self-assessment scale
comprising three questions corresponding to the set of
brief screening questions (SBSQ) developed to detect
inadequate or marginal health literacy in clinical settings
[26]: (1) ‘How often do you have someone help you read
hospital materials?,’ (2) ‘How confident are you filling out
medical forms by yourself?,’ and (3) ‘How often do you
have problems learning about your medical condition be-
cause of difficulty understanding written information?’ We
assigned zero (highest problems with reading or learning/
not at all confident in filling out medical forms) to 4
points (no problems with reading or learning/extremely
confident in filling out medical forms) to the scaled re-
sponses for the three questions. We then summed the
scores to obtain a 0- or 12-point scale, with higher scores
indicating higher health literacy level. The SBSQ sum
score was trichotomized into low (score 0–5), medium
(score 6–9), and high health literacy (score 10–12). The
three brief screening questions have been found effective
in detecting inadequate health literacy [26].
The morbidity variable included the presence of a chronic
disease except for respiratory diseases (i.e., hypothyroidism,
rheumatic diseases (including rheumatoid arthritis, psoriatic
arthritis), diabetes (type I or II), epilepsy, depression, anx-
iety, and cardiovascular diseases (including hypertension,high cholesterol, and heart diseases). An additional open-
ended option was included to capture diseases other
than those specifically mentioned. The respiratory dis-
eases variable included the presence of asthma, allergy,
rhinitis, tonsillitis, sinusitis, or other respiratory tract
conditions.
Ethical approval
The study was approved by the Regional Ethics Commit-
tee South-East in Norway. Before obtaining access to the
online questionnaire, each participant was asked to read
the study description and then answer the question “Are
you willing to participate in the study?” The participants
gave informed consent by ticking the answer “yes” to this
question. All data were handled and stored anonymously.
Statistical analyses
Descriptive statistics were utilized as appropriate. The
Pearson Chi square test was used to compare the maternal
characteristics in smokers and non-smokers and in rela-
tion to the extent of smoking. The reporting of smoking
was initially evaluated separately for pregnant women and
new mothers. However, as there were no significant differ-
ences in reporting of smoking during pregnancy between
pregnant women and new mothers or between pregnant
women in their first (25.2%), second (26.6%), or third tri-
mester (26.7%), the entire study population was used in
the analyses of smoking cessation. Bivariate and multivari-
ate logistic regression was used to explore determinants of
smoking during pregnancy. A p value of < 0.05 was con-
sidered statistically significant. Data are presented as crude
and adjusted odds ratios (OR) with 95% confidence inter-
vals (CI). The multivariate model was built after fitting the
bivariate logistic regression model for all explanatory vari-
ables. Purposeful selection of candidate variables was done
based on a bivariate p value < 0.15. We then fit a reduced
model by removing variables having no role (p value >
0.05), except if they yielded a change larger than 15% in
the beta coefficients of the retained variables. The main ef-
fect model was checked for presence of interactions. The
Hosmer and Lemeshow test was used to assess goodness
of fit of the final multivariate model [28]. Sub-analyses on
maternal status (pregnant or new mothers) were per-
formed to check for recall bias, and sub-analyses on preg-
nancy status (trimester) were performed to check for
inflation/reduction of smoking prevalence across the preg-
nancy. All statistical analyses were carried out using the
Statistical Package for the Social Sciences (SPSS) version
20.0 (IBM® SPSS® Statistics).
Results
Population characteristics
A total of 9615 women accessed the online question-
naire, whereof 9483 (98.6%) completed it. Women with
Table 1 Maternal characteristics of non-smokers and smokers before pregnancy and of continuers and quitters during
pregnancy
Maternal characteristics










(n = 5400) (64.7%) (n = 2944) (35.3%) (n = 771) (26.2%) (n = 2173) (73.8%)
n (%) n (%) n (%) n (%)
Region of residency
Western Europe* 2240 (41.5) 954 (32.4) <0.001 277 (35.9) 677 (31.2) 0.014
Northern Europe† 1922 (35.6) 893 (30.3) 206 (26.7) 687 (31.6)
Eastern Europe§ 1238 (22.9) 1097 (37.3) 288 (37.4) 809 (37.2)
Maternal age
≤ 20 95 (1.8) 151 (5.1) <0.001 51 (6.6) 100 (4.6) 0.051
21-30 2802 (51.9) 1777 (60.4) 459 (59.5) 1318 (60.7)
31-40 2375 (44.0) 976 (33.2) 246 (31.9) 730 (33.6)
> 40 128 (2.4) 40 (1.4) 15 (1.9) 25 (1.2)
Marital status
Married/cohabiting 5232 (96.9) 2694 (91.5) <0.001 668 (86.6) 2026 (93.2) <0.001
Other 168 (3.1) 250 (8.5) 103 (13.4) 147 (6.8)
Highest education level
Less than high school 147 (2.7) 220 (7.5) <0.001 95 (12.3) 125 (5.8) <0.001
High school 1360 (25.2) 1014 (34.4) 348 (45.1) 666 (30.6)
More than high school 3260 (60.4) 1366 (46.4) 230 (29.8) 1136 (52.3)
Other 633 (11.7) 344 (11.7) 98 (12.7) 246 (11.3)
Health literacy**
Low 264 (5.0) 215 (7.4) <0.001 74 (9.8) 141 (6.6) 0.015
Medium 2113 (39.7) 1372 (47.4) 349 (46.3) 1023 (47.8)
High 2943 (55.3) 1305 (45.1) 331 (43.9) 974 (45.6)
Working status
Employed (not as HCP) 3273 (60.7) 1755 (59.7) <0.001 418 (54.4) 1337 (61.6) <0.001
Healthcare personnel (HCP) 772 (14.3) 349 (11.9) 73 (9.5) 276 (12.7)
Housewife 449 (8.3) 208 (7.1) 82 (10.7) 126 (5.8)
Other 898 (16.7) 629 (21.4) 196 (25.5) 433 (19.9)
First language
Same as in country of
residency
5071 (94.1) 2795 (95.2) 0.047 733 (95.3) 2062 (95.1) 0.894
Other 318 (5.9) 142 (4.8) 36 (4.7) 106 (4.9)
Previous children
No 2633 (48.8) 1617 (54.9) <0.001 385 (49.9) 1232 (56.7) 0.001
Yes 2767 (51.2) 1327 (45.1) 386 (50.1) 941 (43.3)
Morbidity not incl. RD††
Yes 541 (18.4) 941 (17.4) 0.291 157 (20.4) 384 (17.7) 0.109
No 2403 (81.6) 4459 (82.6) 614 (79.6) 1789 (82.3)
Respiratory disease§§
Yes 306 (10.4) 603 (11.2) 0.296 71 (9.2) 235 (10.8) 0.235
No 2638 (89.6) 4797 (88.8) 700 (90.8) 1938 (89.2)
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5002 (93.0) 2606 (88.7) <0.001 647 (84.0) 1959 (90.3) <0.001
No, it was not planned 377 (7.0) 333 (11.3) 123 (16.0) 210 (9.7)
Folic acid use*†
Yes 5022 (93.5) 2600 (89.2) <0.001 642 (84.9) 1958 (90.7) <0.001
No 347 (6.5) 314 (10.8) 114 (15.1) 200 (9.3)
Alcohol consumption
during pregnancy
Yes 790 (14.8) 527 (18.0) <0.001 154 (20.1) 373 (17.3) 0.090
No 4556 (85.2) 2398 (82.0) 612 (79.9) 1786 (82.7)
HCP = health care provider; RD = respiratory disease.
Numbers may not add up to total due to missing values. For Folic acid use and Alcohol consumption during pregnancy, the response ‘cannot remember’ was
treated as a missing value. Missing values are less than 5% of the total.
*Includes Austria, France, Italy, Switzerland, the Netherlands, United Kingdom.
†Includes Finland, Iceland, Norway, Sweden.
§Includes Croatia, Poland, Russia, Serbia, Slovenia.
**Measured by a self-assessment scale comprising three questions corresponding to the set of brief screening questions (SBSQ) developed to detect inadequate
or marginal health literacy in clinical settings [26,27].
††Includes the presence of a chronic disease (hypothyroidism, rheumatic diseases (incl. rheumatoid arthritis, psoriatic arthritis), diabetes (type I or II), epilepsy,
depression, anxiety, and cardiovascular diseases (incl. hypertension, high cholesterol, and heart diseases) or others (open-ended option)).
§§Includes the presence of asthma, allergy, rhinitis, tonsillitis, sinusitis, or other respiratory tract conditions.
*†Indicates folic acid use before and/or during pregnancy.
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side Europe were excluded, leaving 8363 participants.
Of these, 8344 women answered the smoking questions.
Figure 1 shows the data selection carried out to achieve
the final study sample.
Of the 8344 women who answered the smoking ques-
tions, 2944 (35.3%) reported smoking before pregnancy. Of
these, 771 (26.2%) continued smoking during pregnancy.
Mean gestational age was 22.3 weeks among non-smokers
and 23.1 weeks among smokers before pregnancy (Mann–
Whitney U test, p = 0.02) and 23.3 weeks among con-
tinuers and 23.0 weeks among quitters during pregnancy,
(Mann–Whitney U test, p = 0.60). Figure 2 shows preva-
lence of smoking before and during pregnancy according
to country, and Table 1 shows maternal characteristics
of smokers and non-smokers before pregnancy and con-
tinuers and quitters during pregnancy. The prevalence of
smoking before pregnancy ranged from 25.0% in Sweden
to 50.0% in Croatia, and smoking during pregnancy ranged
from 4.2% in Iceland to 18.9% in Croatia (Figure 2).
Smokers before pregnancy and non-smokers signifi-
cantly differed in region of residency, age, marital sta-
tus, education level, health literacy, working status, first
language, parity, pregnancy planning, folic acid use be-
fore and/or during pregnancy, and alcohol use during
pregnancy (Table 1). Continuers and quitters during
pregnancy significantly differed in region of residency,
marital status, education level, health literacy, working
status, parity, pregnancy planning, and folic acid use be-
fore and/or during pregnancy (Table 1).Table 2 shows maternal characteristics according to
the extent of smoking during pregnancy. Among the
771 women who continued smoking during pregnancy,
99 (12.8%) smoked less than one cigarette per day, 380
(49.3%) smoked 1–5 cigarettes per day, 203 (26.3%)
smoked 6–10 cigarettes per day, and 88 (11.4%) smoked
more than 10 cigarettes per day. The extent of smoking
only differs significantly in relation to alcohol consump-
tion during pregnancy.
Determinants of smoking before pregnancy
In the bivariate analysis (Table 3), women who lived in
Eastern Europe, were 20 years of age or younger, lived
alone, had high school or less as highest education level,
had low health literacy, did not work or were housewives,
had unplanned pregnancy, did not use folic acid, and
consumed alcohol during pregnancy were more likely to
smoke before pregnancy. Women who were older than
30 years of age, had high health literacy, were employed as
healthcare personnel, and had previous children were less
likely to smoke before pregnancy.
In the multivariate analysis (Table 3), women who lived
in Eastern Europe, lived alone, had high school or less as
highest education level, had unplanned pregnancy, did not
use folic acid, and consumed alcohol during pregnancy
were more likely to smoke before pregnancy. Women who
were older than 30 years of age, were housewives, and had
previous children were less likely to smoke before preg-
nancy. Additionally, there was an interaction effect be-
tween the highest education level variable and the working
Figure 1 Participant flow-chart to achieve final analysis.
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level and working as healthcare personnel was positively
associated with smoking before pregnancy (OR 1.63, 95%
CI 1.13-2.35).
Determinants of continuing smoking during pregnancy
Women who lived in Western Europe, were 20 years of
age or younger, lived alone, had high school or less as
highest education level, had low health literacy, did not
work or were housewives, had previous children, had
unplanned pregnancy, and did not use folic acid were
more likely to continue smoking during pregnancy in
the bivariate analysis (Table 4).
In the multivariate analysis (Table 4), women who
lived in Western and Eastern Europe, lived alone, had
high school or less as highest education level, had lowhealth literacy, were housewives, had previous children,
had unplanned pregnancy, and did not use folic acid
were more likely to continue smoking during pregnancy.
In Northern Europe the prevalence of women continu-
ing smoking during pregnancy with less than high school
as highest education level was 4.8 times higher (48.2% vs.
12.0%) than the prevalence of women with more than high
school as highest education level. For Eastern and Western
Europe, the differences were 2.9 times (52.0% vs. 17.8%)
and 1.8 times (34.1% vs. 19.5%), respectively. In Northern
Europe the prevalence of women continuing smoking dur-
ing pregnancy who lived alone and had less than high
school as highest education level was 4.8 times higher
(54.2% vs. 11.4%) than the prevalence of women who were
married or cohabiting and had more than high school as
highest education level. For Eastern and Western Europe,
Figure 2 Prevalence of women smoking before pregnancy and of women who continue smoking during pregnancy in the countries of
residency based on the total study sample (n = 8344).
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times (20.0% vs. 19.0%), respectively.Determinants of the extent of smoking during pregnancy
There was no significant association between any maternal
characteristic and the extent of smoking during pregnancy
in the bivariate analysis (data not shown). In the multivari-
ate analysis, women who lived in Eastern Europe (OR 2.07,
95% CI 1.12-3.83) and had less than high school as highest
education level (OR 2.76, 95% CI 1.32-5.78) were more
likely to smoke more than 10 cigarettes per day. Women
who were 20 years of age or younger (OR 0.12, 95% CI
0.02-0.90) were less likely to smoke more than 10 ciga-
rettes per day.Discussion
To our knowledge, this study is the first to contribute
multinational comparable descriptive data on the preva-
lence of smoking before and during pregnancy and the
extent of smoking during pregnancy in several European
countries in relation to a wide range of maternal charac-
teristics. The study is also novel in providing insights
into potential determinants for smoking before preg-
nancy, continuing smoking during pregnancy, and the
extent of smoking during pregnancy.Several findings are important for clinical practice. First,
our results are an important reminder that smoking before
and during pregnancy is still prevalent in women across
Europe. Currently, thousands of infants in Europe are ex-
posed to harmful cigarette smoking during fetal life each
year and therefore need continued attention from the
European and national authorities. Second, detection of
maternal characteristics that act as barriers to or facilita-
tors of quitting smoking during pregnancy may assist
healthcare personnel in identifying women who most
likely will need tailored support and inform the important
ongoing work on developing such targeted smoking cessa-
tion interventions among these women. Continuing to
focus on increasing the education level among women in
Europe is an important societal effort that may also result
in healthier pregnancies for mother and child.
We found the highest rates of smoking before pregnancy
in Eastern European countries, ranging from 46.3% in
Russia to 50.0% in Croatia, as well as a more than two-
fold higher risk of smoking before pregnancy in Eastern
Europe compared to Northern Europe. This may be ex-
plained by the ominous shift in tobacco use in general,
and in young women specifically, from high-income coun-
tries to low-and middle-income countries, driven by mar-
keting by tobacco companies specifically targeting women
[29]. Consequently, previous studies [30,31] show that this
Table 2 Maternal characteristics according to extent of smoking during pregnancy
Maternal characteristics










n (%) n (%) n (%) n (%)
Region of residency
Western Europe* 37 (37.4) 135 (35.5) 78 (38.4) 27 (30.7) 0.068
Northern Europe† 36 (36.4) 98 (25.8) 53 (26.1) 19 (21.6)
Eastern Europe§ 26 (26.3) 147 (38.7) 72 (35.5) 42 (47.7)
Maternal age
≤ 20 8 (8.1) 25 (6.6) 17 (8.4) 1 (1.1) 0.293
21-30 61 (61.6) 227 (59.7) 117 (57.6) 53 (60.2)
31-40 29 (29.3) 118 (31.1) 68 (33.5) 31 (35.2)
> 40 1 (1.0) 10 (2.6) 1 (0.5) 3 (3.4)
Marital status
Married/cohabiting 88 (88.9) 324 (85.3) 180 (88.7) 75 (85.2) 0.588
Other 11 (11.1) 56 (14.7) 23 (11.3) 13 (14.8)
Highest education level
Less than high school 9 (9.1) 44 (11.6) 26 (12.8) 16 (18.2) 0.339
High school 39 (39.4) 178 (46.8) 93 (45.8) 37 (42.0)
More than high school 38 (38.4) 112 (29.5) 53 (26.1) 27 (30.7)
Other 13 (13.1) 46 (12.1) 31 (15.3) 8 (9.1)
Health literacy¥¥
Low 9 (9.3) 33 (8.8) 24 (12.1) 8 (9.4) 0.655
Medium 41 (42.3) 184 (49.3) 88 (44.2) 36 (42.4)
High 47 (48.5) 156 (41.8) 87 (43.7) 41 (48.2)
Working status
Employed (not as HCP) 64 (64.6) 210 (55.4) 100 (49.3) 44 (50.6) 0.109
HCP 11 (11.1) 40 (10.6) 16 (7.9) 5 (5.7)
Housewife 7 (7.1) 40 (10.6) 25 (12.3) 10 (11.5)
Other 17 (17.2) 89 (23.5) 62 (30.5) 28 (32.2)
First language
Same as in country of residency 91 (91.9) 361 (95.3) 196 (96.6) 84 (96.6) 0.314
Other 8 (8.1) 18 (4.7) 7 (3.4) 3 (3.4)
Previous children
No 58 (58.6) 196 (51.6) 95 (46.8) 36 (40.9) 0.071
Yes 41 (41.4) 184 (48.4) 108 (53.2) 52 (59.1)
Morbidity not incl. RD**
Yes 21 (21.2) 71 (18.7) 46 (22.7) 19 (21.6) 0.695
No 78 (78.8) 309 (81.3) 157 (77.3) 69 (78.4)
Respiratory disease††
Yes 9 (9.1) 33 (8.7) 18 (8.9) 11 (12.5) 0.731
No 90 (90.9) 347 (91.3) 185 (91.1) 77 (87.5)
Planned pregnancy
Yes/ not completely unexpected 78 (78.8) 317 (83.4) 172 (84.7) 80 (90.9) 0.151
No, it was not planned 21 (21.2) 63 (16.6) 31 (15.3) 8 (9.1)
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Table 2 Maternal characteristics according to extent of smoking during pregnancy (Continued)
Folic acid use§§
Yes 84 (86.6) 322 (86.1) 167 (83.1) 68 (81.9) 0.632
No 13 (13.4) 52 (13.9) 34 (16.9) 15 (18.1)
Alcohol consumption during pregnancy
Yes 35 (35.4) 67 (17.7) 34 (16.9) 18 (20.9) 0.001
No 64 (64.6) 312 (82.3) 167 (83.1) 68 (79.1)
HCP = health care provider; RD = respiratory disease.
¥One women (0.1%) did not provide information on extent of smoking in the sub-population of women smoking during pregnancy (n = 771).
Numbers may not add up to total due to missing values. For Folic acid use and Alcohol consumption during pregnancy, the response ‘cannot remember’ was
treated as a missing value. Missing values are less than 5% of the total.
*Includes Austria, France, Italy, Switzerland, the Netherlands, United Kingdom.
†Includes Finland, Iceland, Norway, Sweden.
§Includes Croatia, Poland, Russia, Serbia, Slovenia.
¥¥Measured by a self-assessment scale comprising three questions corresponding to the set of brief screening questions (SBSQ) developed to detect inadequate
or marginal health literacy in clinical settings [26,27].
**Includes the presence of a chronic disease (hypothyroidism, rheumatic diseases (incl. rheumatoid arthritis, psoriatic arthritis), diabetes (type I or II), epilepsy,
depression, anxiety, and cardiovascular diseases (incl. hypertension, high cholesterol, and heart diseases) or others (open-ended option)).
††Includes the presence of asthma, allergy, rhinitis, tonsillitis, sinusitis, or other respiratory tract conditions.
§§Indicates folic acid use before and/or during pregnancy.
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lence ranging from 15% in Romania to 30% in Poland.
Whether or not a smoker stops smoking after learning of
her pregnancy also depends on the extent of her smoking
habit [32], and we found that pregnant women living in
Eastern Europe were two times more likely to smoke more
than 10 cigarettes per day. The prevalence of smoking
during pregnancy ranged from 4.2% to 18.9% in the 15
European countries in our study. Here there was no strong
trend in smoking during pregnancy status by European re-
gion; there was an approximately 1.5 times higher risk in
Western and Eastern Europe compared to Northern
Europe. Prevalence rates below 10% for smoking during
pregnancy in most of the countries in the Northern and
Western European regions (Iceland, Norway, Sweden,
Austria, Italy, Switzerland, the United Kingdom) in our
study support the recent decline in high-income countries
from 20%-35% in the 1980s to 10%-20% in the early 2000s
[12,22,33-37]. However, given the serious clinical conse-
quences of the adverse outcomes of smoking during preg-
nancy, the public health impact of efficient interventions
to support women to stop smoking during pregnancy
is tremendous across all countries. A recent Cochrane-
review [38] shows that the number of psychosocial inter-
ventions needed to treat for benefit is extraordinarily low,
with approximately 71 interventions to prevent one pre-
term birth and 61 interventions to prevent one infant
being born with low birth weight. Hence, there is a
strong call for a European action plan aiming not only
to reduce the prevalence of smoking during pregnancy
but also to provide efficient support to the women who
struggle to quit.
Our study supports previous research finding that to-
bacco smoking in general is strongly associated with low
socioeconomic status (SES) [39], consequently increasingthe health inequalities between people with high and
low education and high and low incomes. We found that
having less than high school as highest education level
was associated with a four-fold higher risk of smoking
before pregnancy. Furthermore, the more risky behaviors
among smokers before pregnancy in our study – having
unplanned pregnancies, no use of folic acid and alcohol
use during pregnancy – was found to be related to low
SES [40]. In contrast, we speculate that multiparity, be-
ing a housewife, and age older than 30 might be life-
experience barriers to smoking, since the women might
have quit smoking when they were expecting their last
child, and they might have outgrown their smoking
identity as younger independent women as they now are
stay at home caregivers. The association between smok-
ing and living alone also supports this reasoning.
We found a similar association between level of educa-
tion and continuing smoking during pregnancy. There was
three and a half fold increased risk of continuing smoking
during pregnancy among women having less than high
school as highest education level. This is in line with previ-
ous research showing that there are marked socioeco-
nomic differences between women who continue smoking
during pregnancy and those who do not [32,41]. Further,
pregnant women having less than high school as highest
education level were 2.76 times more likely to smoke more
than 10 cigarettes per day. This supports previous research
showing that the higher degree of addiction, the more diffi-
cult it is for women to quit smoking during pregnancy
[42]. We also found that women 20 years of age or youn-
ger were less likely to smoke more than 10 cigarettes per
day, which may indicate that the youngest women have
not yet reached higher degrees of addiction. Interestingly,
the continuers were more often housewives and more
often lived alone, which seems to be a contradiction.
Table 3 Factors associated with smoking before pregnancy (n = 8344)
Unadjusted Adjusted
Maternal characteristics OR 95% CI OR 95% CI
Region of residency
Western Europe* 0.92 0.82-1.02 0.93 0.83-1.05
Northern Europe† 1 1
Eastern Europe§ 1.91 1.70-2.14 2.25 1.99-2.55
Maternal age
≤ 20 2.51 1.93-3.26 1.31 0.97-1.76
21-30 1 1
31-40 0.65 0.59-0.71 0.82 0.74-0.91
> 40 0.49 0.34-0.71 0.57 0.39-0.83
Marital status
Married/cohabiting 1 1
Other 2.89 2.36-3.53 2.22 1.78-2.77
Highest education level
Less than high school 3.57 2.87-4.44 4.23 3.32-5.38
High school 1.78 1.61-1.97 1.95 1.74-2.18
More than high school 1 1
Other 1.30 1.12-1.50 1.48 1.27-1.73
Health literacy**
Low 1.25 1.04-1.52 - -
Medium 1 - -
High 0.68 0.62-0.75 - -
Working status
Employed (not as HCP) 1 1
Healthcare personnel (HCP) 0.84 0.73-0.97 0.99 0.85-1.14
Housewife 0.86 0.73-1.03 0.73 0.60-0.88
Other 1.31 1.16-1.47 0.97 0.85-1.11
First language
Same as in country of residency 1 - -
Other 0.81 0.06-0.99 - -
Previous children
No 1 1
Yes 0.78 0.71-0.86 0.80 0.73-0.89
Morbidity not incl. RD††
Yes 1.07 0.95-1.20 - -
No 1 - -
Respiratory disease§§
Yes 0.92 0.80-1.07 - -
No 1 - -
Planned pregnancy
Yes/not completely unexpected 1 1
No, it was not planned 1.70 1.45-1.98 1.32 1.11-1.56
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Table 3 Factors associated with smoking before pregnancy (n = 8344) (Continued)
Folic acid use*†
Yes 1 1
No 1.75 1.49-2.05 1.66 1.40-1.97
Alcohol consumption during pregnancy
Yes 1.27 1.12-1.43 1.36 1.19-1.55
No 1 1
The outcome variable is categorized as Smoking before pregnancy (yes = 1) and Never smoked (no = 0).
Significant p-values are in bold.
HCP = health care provider; RD = respiratory disease.
Numbers may not add up to total due to missing values. For Folic acid use and Alcohol consumption during pregnancy, the response ‘cannot remember’ was
treated as a missing value. Missing values are less than 5% of the total.
*Includes Austria, France, Italy, Switzerland, the Netherlands, United Kingdom.
†Includes Finland, Iceland, Norway, Sweden.
§Includes Croatia, Poland, Russia, Serbia, Slovenia.
**Measured by a self-assessment scale comprising three questions corresponding to the set of brief screening questions (SBSQ) developed to detect inadequate or
marginal health literacy in clinical settings [26,27].
††Includes the presence of a chronic disease (hypothyroidism, rheumatic diseases (incl. rheumatoid arthritis, psoriatic arthritis), diabetes (type I or II), epilepsy,
depression, anxiety, and cardiovascular diseases (incl. hypertension, high cholesterol, and heart diseases) or others (open-ended option)).
§§Includes the presence of asthma, allergy, rhinitis, tonsillitis, sinusitis, or other respiratory tract conditions.
*†Indicates folic acid use before and/or during pregnancy.
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wife might include the presence of unsupportive partners,
economic vulnerability, and finding the caregiver-role
stressful (having many previous children); hence, smoking
is seen as a habituated response to these life circumstances
[43]. On the other hand, the existence of a supportive non-
smoking husband or another stable partner has a positive
effect on the women being able to quit smoking during
pregnancy. Marital status and number of children are the
best investigated psychosocial factors for smoking during
pregnancy, and our results are consistent with previous re-
sults showing that married women and women with no
previous children have the lowest smoking prevalence
[32,41]. Why having previous children was positively asso-
ciated with continued smoking during pregnancy might be
explained by the women’s personal previous experience of
giving birth to a healthy child despite smoking during
pregnancy, which creates distrust in the scientific evidence
relayed by health professionals [43].
Our study showed that the women who were not able to
quit smoking during pregnancy have low health literacy.
This is supported by the previous finding that women with
low-health literacy may ignore the detrimental effect of
smoking on pregnancy outcome [44]. Previous research
also shows that women with low-health literacy are more
likely to have unplanned pregnancies and no use of folic
acid [44], displaying more risky behaviors like the con-
tinuers in our study, who also had more unplanned preg-
nancies and no use of folic acid. Women who smoke
during pregnancy have previously been shown to be less
likely to participate in positive antenatal care, for example
folic acid intake, explained by a belief that folic acid intake
is not important for fetal development [40]. This under-
lines the detrimental effect of not understanding healthinformation in low-health literacy women, adding to the
health-compromising effects of smoking and placing
the babies of pregnant smokers at a further disadvan-
tage in utero.
In our study, there were no associations between mor-
bidity and smoking before or during pregnancy. In the
current literature, this relationship is not normally dis-
cussed, but we do not know whether this is because
other studies have not found an association or have not
controlled for this variable. However, there is growing
concern over the strong psychological associations, espe-
cially with depression and stress [45-48].
Flemming et al. (2013) calls for recognition of the im-
portance of understanding that why a pregnant women
continues to smoke during pregnancy is closely related to
the contextual factors explaining why she smoked in the
first place: taking a break from daily hardships, dealing
with stress, and keeping up social habits [43]. As preg-
nancy frequently exacerbates the barriers that made it
hard to quit before pregnancy, the now even more com-
plex circumstances reinforce the women’s dependence on
smoking [41,43]. Furthermore, social pressure makes the
women feel embarrassed and guilty, as they are not able to
fulfill the image of the “perfect mother,” which adds so
much anxiety and pressure that the women instead con-
tinue to smoke as a response or at best reduce the number
of cigarettes smoked per day [41,43]. Ebert and Fahy (2007)
therefore suggest that midwives take a woman-centered
approach and appreciate a woman’s life situation, rather
than take the current baby-centered approach focusing
on preventing negative outcomes related to her “bad”
behavior [41]. It is quite plausible that the women who
continue smoking during pregnancy in our study live
their lives in this social context, as they are educationally
Table 4 Factors associated with continuing smoking during pregnancy (n = 2944)
Unadjusted Adjusted
Maternal characteristics OR 95% CI OR 95% CI
Region of residency
Western Europe* 1.37 1.11-1.68 1.46 1.16-1.84
Northern Europe† 1 1
Eastern Europe§ 1.19 0.97-1.46 1.66 1.31-2.10
Maternal age
≤ 20 1.46 1.03-2.09 0.93 0.63-1.39
21-30 1 1
31-40 0.97 0.81-1.16 1.19 0.97-1.45
> 40 1.72 0.90-3.30 1.82 0.91-3.65
Marital status
Married/cohabiting 1 1
Other 2.13 1.63-2.77 1.75 1.30-2.35
Highest education level
Less than high school 3.75 2.78-5.08 3.64 2.58-5.14
High school 2.58 2.12-3.13 2.53 2.05-3.11
More than high school 1 1
Other 1.97 1.50-2.59 1.99 1.49-2.66
Health literacy**
Low 1.54 1.13-2.09 1.49 1.08-2.06
Medium 1 1
High 1.00 0.84-1.19 1.06 0.87-1.28
Working status
Employed (not as HCP) 1 1
Healthcare personnel (HCP) 0.85 0.64-1.12 0.92 0.68-1.23
Housewife 2.08 1.54-2.81 1.43 1.04-1.97
Other 1.45 1.18-1.77 1.21 0.97-1.52
First language
Same as in country of residency 1 - -
Other 0.96 0.65-1.41 - -
Previous children
No 1 1
Yes 1.31 1.11-1.55 1.24 1.03-1.49
Co-morbidity not incl. RD††
No 1 - -
Yes 1.19 0.97-1.47 - -
Respiratory disease§§
No 1 - -
Yes 0.84 0.63-1.11 - -
Planned pregnancy
Yes/not completely unexpected 1 1
No, it was not planned 1.77 1.40-2.25 1.31 1.00-1.72
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Table 4 Factors associated with continuing smoking during pregnancy (n = 2944) (Continued)
Folic acid use*†
Yes 1 1
No 1.74 1.36-2.23 1.59 1.22-2.06
Alcohol consumption during pregnancy
No 1 - -
Yes 1.21 0.98-1.49 - -
The outcome variable is categorized as Continuing smoking during pregnancy (yes = 1) and Quitting smoking during pregnancy (no = 0).
Significant p-values are in bold.
HCP = health care provider; RD = respiratory disease.
Numbers may not add up to total due to missing values. For Folic acid use and Alcohol consumption during pregnancy, the response ‘cannot remember’ was
treated as a missing value. Missing values are less than 5% of the total.
*Includes Austria, France, Italy, Switzerland, the Netherlands, United Kingdom.
†Includes Finland, Iceland, Norway, Sweden.
§Includes Croatia, Poland, Russia, Serbia, Slovenia.
**Measured by a self-assessment scale comprising three questions corresponding to the set of brief screening questions (SBSQ) developed to detect inadequate or
marginal health literacy in clinical settings [26,27].
††Includes the presence of a chronic disease (hypothyroidism, rheumatic diseases (incl. rheumatoid arthritis, psoriatic arthritis), diabetes (type I or II), epilepsy,
depression, anxiety, and cardiovascular diseases (incl. hypertension, high cholesterol, and heart diseases) or others (open-ended option)).
§§Includes the presence of asthma, allergy, rhinitis, tonsillitis, sinusitis, or other respiratory tract conditions.
*†Indicates folic acid use before and/or during pregnancy.
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daily life alone, and display more risky behaviors. Current
smoking cessation efforts are either non-pharmacological
strategies that use cognitive-behavioral, motivational, and
supportive therapies to help women to quit (psychosocial),
or pharmacological interventions, or both. The current bar-
riers to psychosocial interventions are the challenges of
translating the efficacy of research interventions into rou-
tine practice and policy, the high relapse rate postpartum,
and the limited information about the effectiveness of these
interventions for individual women in low- to middle-
income countries, since most interventions have been de-
veloped in high-income countries [38]. For pharmacological
interventions there is currently insufficient evidence to
draw conclusions on the efficacy or safety of adding nico-
tine replacement therapy to behavioral support for smoking
cessation in pregnancy [49]. It is therefore not surprising
that healthcare personnel in Europe that see these women
daily may struggle to give them the best possible support
for smoking cessation during, and preferably also after,
pregnancy. In addition, pregnant women who smoke access
health services for pregnancy-related issues, not smoking
issues, and might therefore feel criticized when the focus
suddenly is on their “bad” behavior. And labelling smoking
in pregnancy solely as a social problem may make health
professionals reluctant to intervene and offer support [50].
Strengths and limitations
An important strength of this study is that data collection
was performed uniformly across all participating countries.
Utilization of the same questionnaire on a multinational
level allows for inter-country comparison of the prevalence
of smoking, continuing smoking during pregnancy, and
the extent of smoking during pregnancy. Additionally,women may feel more comfortable in answering sensitive
questions truthfully on an anonymous, web-based ques-
tionnaire as compared to in a face-to-face interview with a
researcher/health care provider. Further, the utilization of
a web-based questionnaire allowed us to reach a large pro-
portion of the birthing population in several European
countries. However, we cannot exclude the possibility that
the participating women differed from the general birthing
population in other ways than our analysis could control
for. For example, in France, the Netherlands, and Russia
the study sample was a small proportion of the general
birthing population, thus the generalizability of our find-
ings for these specific countries should be considered
when interpreting the results. In addition, having infor-
mation about smoking status prior to pregnancy made it
possible to calculate the “true” rate of cessation, as the pro-
portion of quitters is based on the sample of smokers be-
fore pregnancy and not the total sample of both smokers
and non-smokers before pregnancy.
One limitation of the study is that the information about
smoking is based on self-reported data from two con-
structed smoking questions. More advanced validated
psychometric instruments such as the Fagerstrom Test for
Nicotine Dependence [51], the Nicotine Dependence
Syndrome Scale [52], and the cigarette dependence scale
[53] are available for measuring dependence. In the main
study that our study is based on [25], these instruments
were considered too lengthy to be included. In addition,
using a biochemical marker such as cotinine level in saliva,
urine, or blood to confirm self-reported smoking status
would have been useful, as smoking status based only on
self-report show trends of underestimation [54]. Fur-
thermore, all variables are dependent on the woman’s
perception, accuracy, and recall. For new mothers, data
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recall bias for this group of women cannot be ruled
out. Stratified analyses show that in the total sample
(n = 8344) reporting of alcohol consumption during
pregnancy differed significantly (Pearson Chi square test
p ≤ 0.001) between pregnant women and new mothers;
however, the prevalence was higher for new mothers,
which does not support such a bias. In the sample of
smokers before pregnancy (n = 2944) reporting of respira-
tory disease differed significantly (Pearson Chi square test
p = 0.006) between pregnant women and new mothers,
but again, the prevalence was higher for new mothers,
which does not support such a bias. Inclusion of pregnant
women at any gestational week could have had an impact
on the prevalence of women smoking during pregnancy;
women at an early stage might have not stopped smoking
at the moment of completing the questionnaire but might
have done so later in the pregnancy. However, there were
no significant differences in the reporting of smoking dur-
ing pregnancy between pregnant women and new mothers
or between pregnant women in their first, second, or third
trimester. On the other hand, the participants may have
underreported their actual smoking status irrespective of
gestational week due to the sensitivity of the question. The
questionnaire was only available through Internet web-
sites; therefore, a conventional response rate could not be
calculated. However, recent epidemiological studies indi-
cate reasonable validity of web-based recruitment [55,56].
Also, in Europe the penetration rate of Internet in house-
holds or at work is relatively high among women of child-
bearing age, from about 50% in Russia and Serbia to 100%
in Iceland [57,58]. Hence, the degree to which our findings
can be extrapolated to the target population is based on
the representativeness of the respondents to the general
birthing population in the countries. On average, the
women in the study had higher education and were
slightly more often primiparous than the general birth-
ing population in each country. In addition, the scale
used to assess health literacy has not been validated in a
population of reproductive young women like the po-
pulation in our study. Lastly, this study did not include
potentially important determinants, such as income,
amount smoked before pregnancy, the presence of other
household smokers, and information about nicotine re-
placement therapy. These advantages and limitations
should be kept in mind when interpreting our results.
Conclusions
We found the highest rates of smoking before pregnancy
in Eastern European countries, and a prevalence of smok-
ing during pregnancy ranging from 4.2% to 18.9% in the
15 European countries in the study. Women with fewer
resources living in Western or Eastern Europe are more
likely to continue smoking during pregnancy. They arecharacterized as living alone, having high school or less as
highest education level, having low health literacy, being a
housewife, having previous children, having unplanned
pregnancy, and no use of folic acid. These findings have
implications for antenatal care of women in Europe. Given
the clear significance of the entirely preventable risk factor
for adverse fetal outcomes that smoking during pregnancy
is, knowledge about high-risk groups of women are es-
sential for designing preventive and interventional efforts
at a European and national level. Maternity health care
personnel should be made aware of this high-risk group of
women and manage their care accordingly. Furthermore,
health policy makers and maternity health care personnel
should acknowledge that although effective interventions
to promote smoking cessation in pregnancy exists on re-
search basis, the context of the women’s lives makes it dif-
ficult for them to quit and to remain non-smokers.Competing interests
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